ANIP logo

ANIP

ANI Pharmaceuticals Inc.

$79.48
-$0.52(-0.65%)
39
Overall
55
Value
20
Tech
42
Quality
Market Cap
$1.94B
Volume
167.58K
52W Range
$54.10 - $99.50
Target Price
$110.38

Company Overview

Mkt Cap$1.94BPrice$79.48
Volume167.58KChange-0.65%
P/E Ratio-105.0Open$80.16
Revenue$614.4MPrev Close$80.00
Net Income$-18.5M52W Range$54.10 - $99.50
Div YieldN/ATarget$110.38
Overall39Value55
Quality42Technical20

No chart data available

About ANI Pharmaceuticals Inc.

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. It markets, sells, and distributes its products through wholesalers, retail market chains, distributors and specialty pharmacies, group purchasing organizations, specialty pharmacies, hospitals, clinics, and physicians. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Sector: Healthcare
Industry: Biotechnology

Latest News

Analysts Offer Insights on Healthcare Companies: ANI Pharmaceuticals (ANIP), Abeona Therapeutics (ABEO) and Akebia Therapeutics (AKBA)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on ANI Pharmaceuticals (ANIP – Research Report), Abeona...

Christine Brown13 days ago

Guggenheim Reaffirms Their Buy Rating on ANI Pharmaceuticals (ANIP)

TipRanks Auto-Generated Intelligence Newsdesk21 days ago

ANI Pharmaceuticals issues strong 2025 preliminary results, 2026 outlook

TipRanks Auto-Generated Newsdesk22 days ago
ABCD
1SymbolPriceChangeVol
2ANIP$79.48-0.6%167.58K
3
4
5
6

Get ANI Pharmaceuticals Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.